PDCD1LG2 and lung adenocarcinoma: Moreover, our recent reports indicated that not only PD-L1 but also programmed cell death-ligand-2 (PD-L2), another PD-1 ligand, and IDO1 independently contribute to poor prognoses in patients with resected lung adenocarcinoma (AD) [15, 16].